Intraperitoneal chemotherapy as first-line treatment in the management of epithelial ovarian cancer

被引：0
|
作者：
Rekhraj, S. [1 ]
Kinross, J. [1 ]
Prabhudesai, S. [1 ]
Darzi, A. [1 ]
Ziprin, P. [1 ]
机构：
[1] St Marys Hosp, Imperial Coll London, Dept Biosurg & Surg Technol, London W2 1NY, England
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2007年 / 7卷 / 05期
关键词：
intraperitoneal chemotherapy; cisplatin; carboplatin; paclitaxel; ovarian cancer management;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Recent evidence has suggested improved outcomes following incorporation of intraperitoneal chemotherapy administration with intravenous systemic chemotherapy as first-line treatment of small volume residual epithelial ovarian cancer. This review focuses on the mechanism of actions of the chemotherapeutic drugs and reviews the possible reasons for the superior outcomes of intraperitoneal chemotherapy.
引用
收藏
页码：509 / 517
页数：9
相关论文
共 50 条
  • [1] Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer
    Massard, Christophe
    Lhomme, Catherine
    Pautier, Patricia
    [J]. BULLETIN DU CANCER, 2007, 94 (04) : 398 - 404
  • [2] First-line Chemotherapy in Epithelial Ovarian Cancer
    Bookman, Michael A.
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2012, 55 (01): : 96 - 113
  • [3] Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer - A systematic review with melaanalyses
    Elit, Laurie
    Oliver, Thomas K.
    Covens, Allan
    Kwon, Janice
    Fung, Michael -Kee Fung
    Hirte, Holger W.
    Oza, Amit M.
    [J]. CANCER, 2007, 109 (04) : 692 - 702
  • [4] Intraperitoneal chemotherapy as first-line treatment of newly diagnosed advanced epithelial ovarian cancer: Two centers' data in China
    Xie, X.
    Shen, Y.
    Tang, S.
    Cheng, X.
    Lv, W.
    Wan, X.
    Chen, Z.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 348 - 348
  • [5] Catheter-related complications of intraperitoneal chemotherapy as first-line treatment for advanced epithelial ovarian carcinoma
    Landrum, L. M.
    Gold, M. A.
    Mcmeekin, D. S.
    Walker, J. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 368 - 369
  • [6] Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat, Patrick
    du Bois, Andreas
    Bruchim, Ilan
    Fink, Daniel
    Provencher, Diane M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (02) : 137 - 147
  • [7] The impact of age on first-line chemotherapy treatment of epithelial ovarian cancer and primary peritoneal carcinoma
    Larbi, E.
    Madhuri, T. K.
    Essapen, S.
    Michael, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients
    Romanini, A
    Tanganelli, L
    Carnino, F
    Fanucchi, A
    Lionetto, R
    Pastorino, S
    Cosio, S
    Gadducci, A
    Conte, PF
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 354 - 359
  • [9] Intraperitoneal carboplatin in icodextrin 4% as first-line treatment for epithelial ovarian cancer: A phase I/II trial
    Hofman, L.
    Sludden, J.
    Boddy, A. V.
    Murphy, D. J.
    Ferry, D. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer
    Vasey, PA
    Paul, J
    Birt, A
    Junor, EJ
    Reed, NS
    Symonds, RP
    Atkinson, R
    Graham, J
    Crawford, SM
    Coleman, R
    Thomas, H
    Davis, J
    Eggleton, SPH
    Kaye, SB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2069 - 2080
12345